Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

ADHD Medication Use May Lower Mortality
News
ADHD Medication Use May Lower Mortality
04/09/2024
Medication initiation in patients with attention-deficit/hyperactivity disorder (ADHD) was associated with significantly lower all-cause mortality, according to recent results from an observational nationwide cohort study published in JAMA. 
Medication initiation in patients with attention-deficit/hyperactivity disorder (ADHD) was associated with significantly lower all-cause mortality, according to recent results from an observational nationwide cohort study published in JAMA. 
Medication initiation in...
04/09/2024
Psych Congress Network
rx summit
News
RX Summit Presenters Embrace Harm Reduction for Recovery-Ready Communities
04/09/2024
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for...
04/09/2024
Psychiatry & Behavioral Health
fda
News
FDA Approves Iloperidone for Acute Treatment of Bipolar I Disorder
04/08/2024
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for...
04/08/2024
Psych Congress Network

Advertisement

two animated heads in profile
News
Blonanserin May Improve Social Functioning for Individuals With First-Episode Schizophrenia
04/05/2024
Blonanserin, a novel atypical antipsychotic marketed under the brand name Lonasen, has demonstrated efficacy for improving social functioning in individuals with first-episode schizophrenia.
Blonanserin, a novel atypical antipsychotic marketed under the brand name Lonasen, has demonstrated efficacy for improving social functioning in individuals with first-episode schizophrenia.
Blonanserin, a novel atypical...
04/05/2024
Psych Congress Network
Client at Pharmacy
News
Financial, Insurance Barriers May Interfere with Buprenorphine Dispensing at Pharmacy
04/02/2024
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance...
04/02/2024
Psychiatry & Behavioral Health
Adults With ADHD Report Camouflaging Their Symptoms
News
Adults With ADHD Report 'Camouflaging' Their Symptoms
04/01/2024
Adults with ADHD camouflage, or use strategies to minimize the visibility of symptoms, less than adults with autism but more than age and sex-matched peers without either diagnosis, according to study results published in the journal Autism...
Adults with ADHD camouflage, or use strategies to minimize the visibility of symptoms, less than adults with autism but more than age and sex-matched peers without either diagnosis, according to study results published in the journal Autism...
Adults with ADHD camouflage, or...
04/01/2024
Psych Congress Network

Advertisement

A Black infant with bantu knots holds an alphabet letter block
News
Genetic Links Between Vocabulary and Later-Life ADHD Shift Over Infancy and Toddlerhood
04/01/2024
A larger span of spoken words was genetically linked with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and more ADHD symptoms in infants, but by toddlerhood the genetic relationship was reversed.
A larger span of spoken words was genetically linked with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and more ADHD symptoms in infants, but by toddlerhood the genetic relationship was reversed.
A larger span of spoken words...
04/01/2024
Psych Congress Network
Patients With First-Episode Psychosis Found to Have Cognitive Impairment Before Medication Use
News
Patients With First-Episode Psychosis Found to Have Cognitive Impairment Before Medication Use
03/26/2024
Patients with first-episode psychosis (FEP) were found to have cognitive impairment prior to their first use of antipsychotic medications, particularly with large effect sizes, according to recent meta-analysis results published in JAMA...
Patients with first-episode psychosis (FEP) were found to have cognitive impairment prior to their first use of antipsychotic medications, particularly with large effect sizes, according to recent meta-analysis results published in JAMA...
Patients with first-episode...
03/26/2024
Psych Congress Network
A young women sits on the bus and looks sad
News
COVID-19 Pandemic Accelerated Rate of Antidepressant Dispensing to Young People
03/14/2024
Antidepressant dispensing to adolescents and young adults, already on the rise through 2019, rose 63.5% faster after the outbreak of COVID-19. University of Michigan researchers published their findings in Pediatrics.
Antidepressant dispensing to adolescents and young adults, already on the rise through 2019, rose 63.5% faster after the outbreak of COVID-19. University of Michigan researchers published their findings in Pediatrics.
Antidepressant dispensing to...
03/14/2024
Psych Congress Network

Advertisement

DBT and CBT Adherence Important for Effective Adult ADHD Treatment
News
DBT and CBT Adherence Important for Effective Adult ADHD Treatment
03/13/2024
Adherence to cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT) was found to maximize treatment efficiency for adults with attention-deficit/hyperactivity disorder (ADHD), according to recent results from a randomized...
Adherence to cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT) was found to maximize treatment efficiency for adults with attention-deficit/hyperactivity disorder (ADHD), according to recent results from a randomized...
Adherence to cognitive...
03/13/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use